Does OLAPARIB Cause Haemoglobin decreased? 390 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 390 reports of Haemoglobin decreased have been filed in association with OLAPARIB (Lynparza). This represents 2.1% of all adverse event reports for OLAPARIB.
390
Reports of Haemoglobin decreased with OLAPARIB
2.1%
of all OLAPARIB reports
34
Deaths
117
Hospitalizations
How Dangerous Is Haemoglobin decreased From OLAPARIB?
Of the 390 reports, 34 (8.7%) resulted in death, 117 (30.0%) required hospitalization, and 40 (10.3%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
Yes, Haemoglobin decreased is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which OLAPARIB Alternatives Have Lower Haemoglobin decreased Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL